The clinical study aims to assess the long-term safety and efficacy of the interventional medical device. The clinical study will enrol up to 50 patients aged 18 years and older, who meet specific inclusion and exclusion criteria designed to ensure patient safety and reliable data collection.

Inclusion Criteria (among others):

• Patients over 18 years old (both sex) with full legal capacity who understand the treatment and sign the informed consent and who are medically healthy, except treated condition.

Exclusion Criteria (among others):

• Patients with dental diseases or conditions (except treated condition);
• Patients with unsatisfactory oral hygiene;
• Patients with alcohol, substance abuse, smoking habits, known allergy to collagen;
• Patients with severe or chronic diseases or with systemic inflammation and all patients classified as unhealthy;
• Pregnant or breast feeding women.